Matthew E. Monaghan

Matthew E. Monaghan (chief executive) discloses dealings in 2 companies, chiefly Syneos Health, Inc. and Invacare Corp. Over a trading history stretching from 12 May 2021 to 28 September 2023, the count stands at 10 filings.

On the open market, the record shows 1 purchase worth €44k and 2 sales worth €27k. Netting one side against the other leaves €18k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 6 share grants.

The latest filing, published on 28 September 2023, reports a transaction of €805k in Syneos Health, Inc. The last insider purchase was made public on 14 March 2022, 1,679 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.